Articles tagged with Bleeding
Developed by Z-Medica Corporation and funded by the Office of Naval Research, QuikClot has been proven effective in treating severe arterial hemorrhage with a high success rate. The product is set to be released for consumer use this summer and may also help individuals with specific bleeding disorders.
A new study has found that the drug abciximab can effectively break up secondary clots in stroke patients, with three out of four patients showing significant improvements in symptoms. The study suggests that secondary clots may occur frequently and provides evidence that abciximab may be beneficial for treating them.
A new six-month study investigates continuous combined oral contraception for its potential to prevent periods easily and safely. The study hopes to show whether breakthrough bleeding ceases in women taking this new regimen.
A study has identified a genetic mutation in MCFD2 that causes a rare bleeding disorder by disrupting the transport of clotting factors V and VIII. The researchers propose a new therapeutic target, suggesting a potential alternative to existing anticoagulants.
Researchers found that women who underwent pelvic arterial embolization experienced no significant long-term side effects, including fertility preservation. The procedure also showed a shorter recovery period compared to hysterectomy.
A study by Emory researchers found that controlling blood glucose levels through aggressive insulin therapy can significantly reduce mortality in critically-ill neurological patients. The research, conducted in a neurointensive care unit, used continuous intravenous insulin drip to achieve tighter control of glucose levels.
Emory researchers found that neurointensive care specialists can reduce mean length of stay by 34% for subarachnoid hemorrhage patients and 30% for ischemic stroke patients. Ventilator use also decreased by 76%, with a significant increase in opportunity days, indicating improved quality of care.
Current smokers have a higher risk of hemorrhagic strokes, with a two-fold increase in risk for intracerebral hemorrhage (ICH). The study also found that quitting smoking decreases risk. Smoking damages arterial walls, making them more prone to rupture, establishing it as a risk factor for ICH.
The new mat mimics natural clotting processes by creating fibers of similar dimensions to those found in the body. It can be used for minor cuts or severe battlefield wounds, promoting clotting and eventual absorption by the body.
Results from THRIVE III study demonstrate that oral EXANTA is effective in preventing recurrence of VTE events by 84% compared to placebo. The data also show no significant increase in total bleeding events for EXANTA.
A recent clinical trial found that a combination of estrogen and micronized progesterone causes fewer days and less intense bleeding than commonly used hormone replacement therapies. The study suggests that estrogen plus micronized progesterone (MP) may be the form of HRT with the least bleeding and potentially lower health risks.
A study published by the American College of Gastroenterology found that wireless capsule endoscopy outperformed traditional push enteroscopy in detecting small intestine lesions causing obscure GI bleeding. The technology identified potential sources of bleeding in 70% of patients, compared to 45% with push enteroscopy.
Women with heavy menstrual periods experience significant economic loss due to missed work and lower health ratings. The study estimates that women who miss work because of heavy periods lose approximately $1692 a year.
Researchers at Washington University School of Medicine have found that a defective form of vWF causes chemical bonds to persist longer than they should, leading to a bleeding disorder. The defect in the vWF protein changes the kinetics of the chemical bonds between the protein and platelets, resulting in the disease.
Abnormalities in the mouth, like swollen gums and oral sores, can signal serious medical conditions. Regular oral exams can detect signs of nutritional deficiencies and systemic diseases.
QuikClot is a granulated material that rapidly absorbs all liquid in the blood and leaves behind clotting factors to effect coagulation within seconds. The product has been cleared by the FDA and is being distributed to US troops in Afghanistan, with plans for wider use in military and civilian settings.
A study by Michigan Medicine found that ER doctors can safely give stroke clot-busters, but patients need to reach the ER quickly. The study showed a complication rate similar to dedicated stroke teams, with 7% serious bleeding complications.
A new wireless imaging test has been developed to identify the source of gastrointestinal bleeding, enabling earlier treatment. The test, using a video capsule, was successful in diagnosing conditions not previously detected by conventional tests in 76% of cases.
A new synthetic antithrombotic drug, fondaparinux, has been shown to reduce the risk of deep-vein thrombosis (DVT) in patients after hip-replacement surgery. The study found a 26% reduction in DVT risk among patients given fondaparinux.
A new study has found that heavy drinkers are at a higher risk of bleeding stroke, with hypertension and genetic factors also contributing to the condition. The research, conducted by the University of Cincinnati College of Medicine, involved 107 individuals with subarachnoid hemorrhage (SAH) and 197 without stroke.
A study published in Nature Medicine found that mice without a functional vitamin C transporter gene died shortly after birth due to severe health problems. The research suggests that vitamin C plays a crucial role in fetal lung development, which could have implications for premature infants and pregnant women.
A study by Dr. David Veenstra at the University of Washington identified two genetic variants associated with an increased risk of severe bleeding incidents in patients taking warfarin. Patients with these variants required longer time to achieve stable dosing, suggesting potential for dose adjustment and closer monitoring.
The study found that childhood hemorrhagic strokes declined by 79%, while ischemic strokes declined by only 19%. Black children were more than twice as likely to die from stroke-related deaths, highlighting the need for further research into risk factors and prevention strategies.
The Coordinated Stroke Strategy led to a dramatic increase in stroke treatment rates, from 3.5 patients per month to an average of six patients per month. Intracerebral hemorrhage hospitalization rates varied by gender and geography, with higher rates among men and in the southern United States.
A Canadian study finds that home births attended by midwives have comparable perinatal outcomes to hospital births, including lower rates of maternal infection and neonatal complications. However, the authors recommend ongoing monitoring for rare adverse outcomes such as hemorrhage and ventilator support.
A study in Annals of Internal Medicine finds that accurate profiling of physician care depends on study design, and that most quality initiatives fail to adjust for patient characteristics. Additionally, researchers estimate that colonoscopy is a cost-effective strategy for investigating rectal bleeding in young people
Researchers have made a breakthrough in stopping internal bleeding without surgery, using traditional ultrasound to locate bleeding combined with HIFU. The technique has been shown to be effective in stopping bleeding in blood vessels and solid organs like the liver and spleen, offering new hope for emergency medical treatment.
Researchers at UNC developed a technique to deliver oxygen-carrying fluid to resuscitate the heart after cardiac arrest. The method, selective aortic arch perfusion (SAAP), has shown promising results in animal studies and may help save trauma victims by allowing surgeons to repair damage.
A study published in Ethnicity and Disease found that cocaine use and hypertension are major risk factors for brain hemorrhage in young African Americans. The researchers also discovered that the incidence of intracerebral hemorrhage is nearly 50 times higher in African Americans than in white patients.
A Yale study found that retinal hemorrhaging caused by birth can clear up within two to four weeks, but prolonged cases may indicate child abuse. The study's results have implications for evaluating suspected cases of child abuse and may assist legal teams in preparing a more precise defense or prosecution.
A comprehensive study found that women who underwent tubal sterilization have no greater risk of menstrual abnormalities than those who did not. However, the study also reported a secondary finding of reduced menstrual pain and bleeding among sterilized women, which may be due to chance or unknown factors.
Researchers are testing a new treatment for intracerebral hemorrhage with intraventricular extension, a rare form of stroke that affects younger people and African-Americans. The study aims to reduce mortality rates by using small doses of tissue plasminogen activator (TPA), a clot-buster commonly used in heart attacks and many strokes.
A new product derived from a marine alga has been developed by Marine Polymer Technologies, which can induce blood clot formation and stop severe bleeding. The bandage is lightweight, easy to transport, and has a shelf life of up to two years, presenting less risk for disease transmission.
Researchers have identified a compound with blood clot-forming abilities without normal clotting proteins, promising reduced bleeding on the battlefield. The Marine Polymer Technologies company found that poly-n-acetyl glucosamine effectively stops severe bleeding even without fibrin or thrombin.
A palm-sized ultrasound scanner can provide images of internal organs and detect sites of internal bleeding, assisting medics in treating battle victims according to injury severity. Prototype devices are currently under evaluation in civilian and military hospitals.
A new 10-point system helps neurologists determine if clot-dissolving therapy is safe and effective for stroke patients. The scale assesses brain damage from front to back, providing more accurate diagnosis and treatment decisions.
Stroke patients in rural areas are being transported to comprehensive stroke medical centers via helicopters, where they can receive life-saving treatment and reduce disability. The study found that all five TPA-treated patients survived, with two having excellent outcomes and one major deficit.
A new experimental drug derived from snake venom, ANCROD, has shown promising results in reversing the physical and mental effects of stroke. In a 500-person trial, 42% of patients treated with ANCROD within three hours of stroke onset recovered their previous faculties.
The study found that the risk of rupture for small aneurysms (less than 10 mm) is low, especially in patients without a history of subarachnoid hemorrhage. The investigators advise against surgery for most patients with small aneurysms and no history of brain hemorrhage, suggesting monitoring as an alternative.
A study found that genetic variations in apolipoprotein E, specifically the e4 allele, are associated with an increased risk of intracerebral hemorrhage (ICH) in African Americans. ICH occurs at a younger age among African Americans compared to Caucasians, suggesting a possible genetic link.
A study published in the Journal of Neurosurgery found a significant link between smoking and cerebral blood-vessel damage. Smokers are nearly five times more likely to develop vasospasm, a violent constriction of arterial walls that can lead to stroke-like symptoms.